Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) EBIT Margin (2020 - 2025)

Historic EBIT Margin for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to 2655.19%.

  • iSpecimen's EBIT Margin fell 25911300.0% to 2655.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 361.81%, marking a year-over-year decrease of 2678900.0%. This contributed to the annual value of 136.99% for FY2024, which is 244900.0% down from last year.
  • Latest data reveals that iSpecimen reported EBIT Margin of 2655.19% as of Q3 2025, which was down 25911300.0% from 255.41% recorded in Q2 2025.
  • iSpecimen's 5-year EBIT Margin high stood at 31.81% for Q1 2021, and its period low was 2655.19% during Q3 2025.
  • Moreover, its 5-year median value for EBIT Margin was 93.64% (2022), whereas its average is 254.81%.
  • In the last 5 years, iSpecimen's EBIT Margin skyrocketed by 1429900bps in 2024 and then plummeted by -25911300bps in 2025.
  • Quarter analysis of 5 years shows iSpecimen's EBIT Margin stood at 78.26% in 2021, then rose by 8bps to 72.31% in 2022, then plummeted by -54bps to 111.49% in 2023, then tumbled by -255bps to 395.83% in 2024, then crashed by -571bps to 2655.19% in 2025.
  • Its EBIT Margin stands at 2655.19% for Q3 2025, versus 255.41% for Q2 2025 and 154.93% for Q1 2025.